糖尿病与非糖尿病CKD进展的新风险因素:CRIC研究
CRIC前瞻性队列纳入3379例CKD成人,随访至12.3年,47%合并糖尿病,评估30项基线风险因素与eGFR斜率及复合终点(eGFR减半或启动肾脏替代治疗)的关联。糖尿病者中CXCL12、NT-proBNP及尿NGAL较高与复合终点风险约增2倍及以上相关;非糖尿病者中低血清碳酸氢盐及高hs-TnT、NT-proBNP、尿NGAL与复合终点风险增1.5倍及以上相关。
要点
- 糖尿病CKD者CXCL12、NT-proBNP、尿NGAL较高与进展风险约增2倍及以上相关。
- 非糖尿病CKD者低碳酸氢盐及高hs-TnT、NT-proBNP、尿NGAL与进展风险增1.5倍及以上相关。
- 心脏标志物、CXCL12及尿NGAL的关联强度与收缩压≥140mmHg相当。
核心结论
- 心脏标志物、血浆CXCL12及尿NGAL与CKD进展的强关联可与收缩压≥140mmHg相比,值得进一步研究其机制及用于风险分层的可能。
研究设计与样本
- CRIC为美国7个临床中心开展的前瞻性队列研究,纳入3379例CKD成人,随访至12.3年,47%合并糖尿病。
主要发现
- 非糖尿病与糖尿病者平均eGFR斜率分别为-1.4±3.3与-2.7±4.7mL/min/1.73m2/年。
- 糖尿病者中CXCL12、NT-proBNP及尿NGAL较高与复合终点多变量校正风险约增2倍及以上相关。
- 非糖尿病者中低血清碳酸氢盐及高hs-TnT、NT-proBNP、尿NGAL与复合终点风险增1.5倍及以上相关。
关键数值与推荐
- 复合终点为eGFR减半或启动肾脏替代治疗。
- 基线评估30项社会人口学、行为、临床及生化领域风险因素。
临床怎么用
- 对CKD患者可关注心脏标志物、CXCL12及尿NGAL以辅助识别进展高风险亚组。
局限性
- 观察性设计无法进行因果推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Identification of novel risk factors for chronic kidney disease (CKD) progression may inform mechanistic investigations and improve identification of high-risk subgroups. The current study aimed to characterize CKD progression across levels of numerous risk factors and identify independent risk factors for CKD progression among those with and without diabetes. STUDY DESIGN: The Chronic Renal Insufficiency Cohort (CRIC) Study is a prospective cohort study of adults with CKD conducted at 7 US clinical centers. SETTING & PARTICIPANTS: Participants (N=3,379) had up to 12.3 years of follow-up; 47% had diabetes. PREDICTORS: 30 risk factors for CKD progression across sociodemographic, behavioral, clinical, and biochemical domains at baseline. OUTCOMES: Study outcomes were estimated glomerular filtration rate (eGFR) slope and the composite of halving of eGFR or initiation of kidney replacement therapy. ANALYTICAL APPROACH: Stepwise selection of independent risk factors was performed stratified by diabetes status using linear mixed-effects and Cox proportional hazards models. RESULTS: Among those without and with diabetes, respectively, mean eGFR slope was-1.4±3.3 and-2.7±4.7mL/min/1.73m2 per year. Among participants with diabetes, multivariable-adjusted hazard of the composite outcome was approximately 2-fold or greater with higher levels of the inflammatory chemokine CXCL12, the cardiac marker N-terminal pro-B-type natriuretic peptide (NT-proBNP), and the kidney injury marker urinary neutrophil gelatinase-associated lipocalin (NGAL). Among those without diabetes, low serum bicarbonate and higher high-sensitivity troponin T, NT-proBNP, and urinary NGAL levels were all significantly associated with a 1.5-fold or greater rate of the composite outcome. LIMITATIONS: The observational study design precludes causal inference. CONCLUSIONS: Strong associations for cardiac markers, plasma CXCL12, and urinary NGAL are comparable to that of systolic blood pressure≥140mm Hg, a well-established risk factor for CKD progression. This warrants further investigation into the potential mechanisms that these markers indicate and opportunities to use them to improve risk stratification.
引用
- Anderson AH, Xie D, Wang X, et al. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020. PMID: 32866540. doi:10.1053/j.ajkd.2020.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。